Viviane Monges is a Non-Executive Director on the Board of Directors of ADC Therapeutics.
Ms. Monges has more than 30 years of executive-level financial leadership experience with global corporations, predominantly in the pharmaceutical industry. From 2015 to 2017, she served as Chief Financial Officer (CFO) of the Business Excellence Division at Nestlé, S.A. Prior to that, Ms. Monges served as Group CFO at Galderma S.A; EMEA CFO and then Global CFO at the OTC Division of Novartis; CFO of the Europe Region unit and CFO of the Global Pharma Business unit at Wyeth Pharmaceuticals/Pfizer.
Ms. Monges also serves on the Board of Directors of DBV Technologies, Novo Holdings A/S, Voluntis S.A., and Union Chimique Belge Biopharmaceutical Company S.A. (UCB). She served on the board of Idorsia from 2018 to 2021. She holds a B.A. and an M.B.A. in finance and public administration from the École Supérieure de Commerce de Paris.